This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Alesta Therapeutics Bv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jennifer Borthwick and GCN2 Modulator Compounds.
Introduction
Jennifer Borthwick is an inventor associated with Hertfordshire, Great Britain. Her patent work includes a disclosure concerning compounds that modulate General Control Nondepressible 2 (GCN2).
Latest Patents
Borthwick is associated with one patent, titled “GCN2 Modulator Compounds.” The disclosure describes novel compounds of Formula (1), or salts thereof, with substituents defined in the patent. It also describes their potential use in treating, preventing, ameliorating, controlling, or reducing the risk of disorders associated with GCN2. The supplied information lists 1 patent.
Career Highlights
Borthwick is associated with Alesta Therapeutics BV. Her listed patent reflects work on compounds targeting GCN2 and their potential therapeutic applications.
Collaborations
The supplied information identifies Sebastian Bernales and Brahmam Pujala as Borthwick’s coworkers.
Conclusion
Jennifer Borthwick’s recorded patent activity centers on GCN2 modulator compounds and their potential use in addressing disorders associated with this target.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile